Recombinant Human EPHA1 Protein，His

EPHA1, a member of the Eph receptor tyrosine kinase family, plays a crucial role in various biological processes, including cell migration, differentiation, and tissue morphology. Its involvement in neurogenesis, angiogenesis, and the regulation of the immune response has made EPHA1 a significant focus in cancer research, as altered expression or function of this receptor is often associated with tumor progression and metastasis. Given its promising role as a biomarker and therapeutic target, the study of EPHA1 recombinant protein has gained traction. Researchers are interested in understanding its signaling pathways and interactions with ephrin ligands, which can potentially reveal novel mechanisms of disease. Furthermore, the generation of EPHA1 recombinant proteins allows for the exploration of its structure-function relationships and the development of targeted therapies. By utilizing advanced techniques such as protein engineering and biotechnology, scientists aim to create stable and functional EPHA1 proteins that can be used in assays and experimental models. This research not only sheds light on the fundamental biology of EPHA1 but also paves the way for innovative approaches in cancer treatment and regenerative medicine, highlighting the therapeutic potential of manipulating this receptor's pathways. As studies progress, insights gained from EPHA1 recombinant protein research may contribute to the development of effective diagnostics and targeted therapies for diseases where EPHA1 plays a pivotal role.